Theseus Pharmaceuticals I... (THRX)
NASDAQ: THRX
· Real-Time Price · USD
4.07
0.01 (0.25%)
At close: Feb 13, 2024, 9:59 PM
Theseus Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -13.5M | -14.8M | -14.59M | -13.72M | -14.74M | -11.65M | -10.5M | -8.66M | -7.37M | -6.81M | -4.47M |
Depreciation & Amortization | 22K | 21K | 20K | 20K | 18K | 11K | 1K | 1K | n/a | n/a | 1K |
Stock-Based Compensation | 3.64M | 3.57M | 2.99M | 2.38M | 4.47M | 2.52M | 2.04M | 1.58M | 1.29M | 936K | 548K |
Other Working Capital | 1.41M | 2.17M | 2.8M | -1.41M | 2.46M | 1.02M | 505K | -1.86M | 168K | -1.26M | -1.15M |
Other Non-Cash Items | 194K | 53K | -598K | -361K | 252K | -81K | -160K | -4.25M | n/a | n/a | n/a |
Deferred Income Tax | -1.73M | -1.24M | n/a | n/a | n/a | n/a | n/a | 4.25M | n/a | n/a | n/a |
Change in Working Capital | 356K | 2.36M | -6.46M | 1.75M | 2.77M | 1.1M | 928K | -2.84M | 758K | -887K | -1.28M |
Operating Cash Flow | -11.03M | -10.04M | -18.63M | -9.94M | -7.23M | -8.1M | -7.68M | -9.91M | -5.32M | -6.76M | -5.2M |
Capital Expenditures | -50K | -11K | 11K | -11K | -63K | -354K | -27K | 12K | n/a | n/a | n/a |
Cash Acquisitions | n/a | 51.93K | n/a | 166.89M | -49.6M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -9.62M | -83.42M | -56.64M | -36.12M | -61.84M | -2.81M | -90.67M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 19.75M | 31.49M | 40.88M | 25M | 49.6M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -51.93K | -11K | -166.89M | 49.6M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 10.08M | -51.94M | -15.76M | -11.13M | -12.3M | -3.16M | -90.7M | 12K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 142K | 49.49M | 112K | n/a | 70K | n/a | 164.17M | -1.48M | 1.2M | 99.89M |
Financial Cash Flow | n/a | 142K | 49.49M | 112.00 | n/a | 70.00 | n/a | 164.17M | -1.48M | 1.2M | 99.89M |
Net Cash Flow | -949K | -61.84M | 15.09M | -20.96M | -19.53M | -11.19M | -98.38M | 154.26M | -6.8M | -5.56M | 94.69M |
Free Cash Flow | -11.08M | -10.05M | -18.62M | -9.95M | -7.29M | -8.45M | -7.71M | -9.9M | -5.32M | -6.76M | -5.2M |